BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260825T140000
DTEND;TZID=Europe/Zurich:20260825T180000
DTSTAMP:20260610T043449
CREATED:20260521T211126Z
LAST-MODIFIED:20260521T211126Z
UID:2789-1787666400-1787680800@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2026 MedTech in Recalibration: Staying Ahead in Regulation\, AI\, and the Deal Landscape
DESCRIPTION:Sidley\, ISS AG\, and Swiss Medtech invite you to our annual Swiss MedTech afternoon\, bringing together regulators\, industry leaders\, legal thought leaders\, and scientific advisers to exchange insights on the evolving MedTech landscape. \n \n\n\n\nRSVP here. \n\n\n\n2026 is a pivotal year for Swiss and European MedTech. MDR and IVDR revisions are progressing\, while the AI Act timeline for medical devices has been adjusted under the Digital Omnibus agreement. \nAt the same time\, EU simplification initiatives are reshaping sustainability\, digitalization\, and reporting obligations. \nManufacturers also face growing geopolitical and economic pressures\, including supply chain disruption\, trade uncertainty\, and rising costs. \nIn Switzerland\, proposed Swissmedic supervisory fees\, the TPITO revision and the rollout of swissdamed are adding further complexity\, while increased M&A activity continues to reshape the sector. \nKey highlights on the agenda include: \nThe European Regulatory Reset: Navigating MDR/IVDR Revision and Omnibus\nWhat is changing\, what is at stake\, and how Swiss manufacturers should prepare for the next phase of the European regulatory framework. \nOperational Resilience in a Volatile Market Environment\nHow trade tensions\, supply chain dependencies\, sustainability and PFAS-related requirements\, and regulatory change are influencing manufacturing\, sourcing\, and long-term decisions. \nSwitzerland: Additional Economic Pressure on Manufacturers\nSwissmedic supervisory fees\, swissdamed implementation\, proposed TPITO revisions\, and evolving anti-corruption expectations — and what they mean for Swiss manufacturers. \nAI Act: From Uncertainty to Implementation\nThe revised timeline for AI-enabled medical devices and the practical implications for MDSW strategy\, data governance\, and compliance planning. \nStrategic Deals in MedTech\nHow AI\, market access\, supply chain resilience\, and regulatory complexity are reshaping acquisition strategies\, valuations\, and investment decisions. \nWho should attend? \nExecutives\, investors\, in-house counsel\, and regulatory managers interested in and/or facing regulatory issues in Switzerland. \nFor more information or questions\, please contact Geneva Events.
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2026-medtech-in-recalibration-staying-ahead-in-regulation-ai-and-the-deal-landscape/
LOCATION:Casino Bern\, Casinoplatz 1\, 3011\, Bern\, Switzerland
END:VEVENT
END:VCALENDAR